Kamada Ltd.

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP
M6240T109
SEDOL
B0L2CR5
CIK
0001567529
www.kamada.com
LEI:
©
FIGI: BBG000C0KFB7
KMDA
Kamada Ltd.
GICS: - · Sector: Healthcare · Sub-Sector: Drug Manufacturers—Specialty & Generic
NAME
Kamada Ltd.
ISIN
IL0010941198
TICKER
KMDA
MIC
XNAS
REUTERS
KMDA.OQ
BLOOMBERG
KMDA US
BUILD THEMEFOLIO SHARE IDEAS DISCUSS
LEVERAGE INVEST
EN 728x90
Financial Intelligence
360° iHub Crowd iFeed ATH Tracker Index Tracker ETF TF Spicy2 X-Billboard
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants

GlobeNewswire is an important news source that provides investors with company-related information. In particular, it deals with events that may be relevant to the listing of companies or tradable financial instruments. You can access the complete overview of all reports via this link.

Wed, 14.08.2024

REHOVOT, Israel and HOBOKEN, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced financial results for the three and six months ended June 30, 2024.

Research & Analysis
Read more
Wed, 01.05.2024

REHOVOT, Israel and HOBOKEN, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that it will release financial results for the first quarter ended March 31, 2024, prior to the open of the U.S. financial markets on Wednesday, May 8, 2024.

Research & Analysis
Read more
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements